Antihypertensive treatment and risk factors for syncope in asymptomatic aortic stenosis patients with hypertension

Clin Exp Hypertens. 2022 Feb 17;44(2):191-197. doi: 10.1080/10641963.2021.1883047. Epub 2021 Dec 7.

Abstract

Background: Evidence for treating hypertension in patients with asymptomatic aortic valve stenosis(AS) is scarce.

Objectives: Given the paucity of data on the relationship between syncope and antihypertensive treatment in aortic stenosis. This study sought to investigate this association in patients admitted to our hospital.

Methods: A total of 158 patients with asymptomatic moderate or severe aortic stenosis were analyzed. Follow-up was conducted by clinic visit, telephone contact, or review of electronic medical records. Outcomes were syncope.

Results: Hypertension were documented in 90 of the 158 patients with moderate or severe AS, and 77 of them received antihypertensive medications. During an average 28 months follow-up period, the occurrence of syncope was observed in 13 patients. Among them, 8 were in antihypertensive group (n = 77) and 5 in normotensive group (n = 68). There was no significant difference in incidence of syncope between the two groups. Patients with treated hypertension and syncope had a lower stroke volume index (SVi), a higher valve arterial impedance (ZVA), a smaller SAC than those without. Kaplan-Meier analysis showed that there was no significant difference in syncope cumulative incidence between antihypertensive group and normotensive group (log rank P = .478). Multivariate cox regression analysis showed that both ZVA (hazard ratio:19.006, 95% confidence interval: 4.664 to77.448;P = .002) and LVMI (hazard ratio:1.484, 95% confidence interval: 1.427 to 5.157;P = .016) were associated with development of syncope, whereas hypertension were not related independently to syncope (hazard ratio:0.935, 95% confidence interval: 0.786 to3.173; P = .869).

Conclusions: In patients with moderate or severe AS, concomitant hypertension, and antihypertensive treatment didn't increase the occurrence of syncope, whereas higher ZVA was independently associated with greater risk of syncope.

Keywords: Aortic stenosis; antihypertension treatment; syncope.

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Aortic Valve Stenosis* / complications
  • Aortic Valve Stenosis* / epidemiology
  • Humans
  • Hypertension* / complications
  • Hypertension* / drug therapy
  • Hypertension* / epidemiology
  • Risk Factors
  • Severity of Illness Index
  • Stroke Volume
  • Syncope / epidemiology
  • Syncope / etiology

Substances

  • Antihypertensive Agents